line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,KOLTEPATIL.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.361278,KOLTEPATIL.NS
Normalized EBITDA,2025-03-31 00:00:00,2273600000.0,KOLTEPATIL.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,KOLTEPATIL.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Reconciled Depreciation,2025-03-31 00:00:00,142800000.0,KOLTEPATIL.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,12968400000.0,KOLTEPATIL.NS
EBITDA,2025-03-31 00:00:00,2273600000.0,KOLTEPATIL.NS
EBIT,2025-03-31 00:00:00,2130800000.0,KOLTEPATIL.NS
Net Interest Income,2025-03-31 00:00:00,-419100000.0,KOLTEPATIL.NS
Interest Expense,2025-03-31 00:00:00,419100000.0,KOLTEPATIL.NS
Interest Income,2025-03-31 00:00:00,,KOLTEPATIL.NS
Normalized Income,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Total Expenses,2025-03-31 00:00:00,15557700000.0,KOLTEPATIL.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,KOLTEPATIL.NS
Diluted Average Shares,2025-03-31 00:00:00,76168692.0,KOLTEPATIL.NS
Basic Average Shares,2025-03-31 00:00:00,76005706.0,KOLTEPATIL.NS
Diluted EPS,2025-03-31 00:00:00,13.99,KOLTEPATIL.NS
Basic EPS,2025-03-31 00:00:00,14.02,KOLTEPATIL.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Net Income Common Stockholders,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income,2025-03-31 00:00:00,1065600000.0,KOLTEPATIL.NS
Minority Interests,2025-03-31 00:00:00,-27700000.0,KOLTEPATIL.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,1093300000.0,KOLTEPATIL.NS
Net Income Extraordinary,2025-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Continuous Operations,2025-03-31 00:00:00,1093300000.0,KOLTEPATIL.NS
Tax Provision,2025-03-31 00:00:00,618400000.0,KOLTEPATIL.NS
Pretax Income,2025-03-31 00:00:00,1711700000.0,KOLTEPATIL.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,463500000.0,KOLTEPATIL.NS
Special Income Charges,2025-03-31 00:00:00,0.0,KOLTEPATIL.NS
Other Special Charges,2025-03-31 00:00:00,,KOLTEPATIL.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-419100000.0,KOLTEPATIL.NS
Total Other Finance Cost,2025-03-31 00:00:00,,KOLTEPATIL.NS
Interest Expense Non Operating,2025-03-31 00:00:00,419100000.0,KOLTEPATIL.NS
Interest Income Non Operating,2025-03-31 00:00:00,,KOLTEPATIL.NS
Operating Income,2025-03-31 00:00:00,1616100000.0,KOLTEPATIL.NS
Operating Expense,2025-03-31 00:00:00,2589300000.0,KOLTEPATIL.NS
Other Operating Expenses,2025-03-31 00:00:00,1504900000.0,KOLTEPATIL.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,142700000.0,KOLTEPATIL.NS
Amortization,2025-03-31 00:00:00,,KOLTEPATIL.NS
Depreciation Income Statement,2025-03-31 00:00:00,142700000.0,KOLTEPATIL.NS
Selling General And Administration,2025-03-31 00:00:00,,KOLTEPATIL.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,KOLTEPATIL.NS
General And Administrative Expense,2025-03-31 00:00:00,,KOLTEPATIL.NS
Rent And Landing Fees,2025-03-31 00:00:00,,KOLTEPATIL.NS
Gross Profit,2025-03-31 00:00:00,4205400000.0,KOLTEPATIL.NS
Cost Of Revenue,2025-03-31 00:00:00,12968400000.0,KOLTEPATIL.NS
Total Revenue,2025-03-31 00:00:00,17173800000.0,KOLTEPATIL.NS
Operating Revenue,2025-03-31 00:00:00,17173800000.0,KOLTEPATIL.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-11221871.031466,KOLTEPATIL.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.047834,KOLTEPATIL.NS
Normalized EBITDA,2024-03-31 00:00:00,411800000.0,KOLTEPATIL.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,KOLTEPATIL.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-234600000.0,KOLTEPATIL.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,-693500000.0,KOLTEPATIL.NS
Reconciled Depreciation,2024-03-31 00:00:00,141900000.0,KOLTEPATIL.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,10760200000.0,KOLTEPATIL.NS
EBITDA,2024-03-31 00:00:00,411800000.0,KOLTEPATIL.NS
EBIT,2024-03-31 00:00:00,269900000.0,KOLTEPATIL.NS
Net Interest Income,2024-03-31 00:00:00,-978600000.0,KOLTEPATIL.NS
Interest Expense,2024-03-31 00:00:00,978600000.0,KOLTEPATIL.NS
Interest Income,2024-03-31 00:00:00,76000000.0,KOLTEPATIL.NS
Normalized Income,2024-03-31 00:00:00,-235521871.031466,KOLTEPATIL.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,-693500000.0,KOLTEPATIL.NS
Total Expenses,2024-03-31 00:00:00,13345700000.0,KOLTEPATIL.NS
Rent Expense Supplemental,2024-03-31 00:00:00,22200000.0,KOLTEPATIL.NS
Diluted Average Shares,2024-03-31 00:00:00,76041667.0,KOLTEPATIL.NS
Basic Average Shares,2024-03-31 00:00:00,76041667.0,KOLTEPATIL.NS
Diluted EPS,2024-03-31 00:00:00,-9.12,KOLTEPATIL.NS
Basic EPS,2024-03-31 00:00:00,-9.12,KOLTEPATIL.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,-693500000.0,KOLTEPATIL.NS
Net Income Common Stockholders,2024-03-31 00:00:00,-693500000.0,KOLTEPATIL.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income,2024-03-31 00:00:00,-693500000.0,KOLTEPATIL.NS
Minority Interests,2024-03-31 00:00:00,-18700000.0,KOLTEPATIL.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,-674800000.0,KOLTEPATIL.NS
Net Income Extraordinary,2024-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Continuous Operations,2024-03-31 00:00:00,-674800000.0,KOLTEPATIL.NS
Tax Provision,2024-03-31 00:00:00,-33900000.0,KOLTEPATIL.NS
Pretax Income,2024-03-31 00:00:00,-708700000.0,KOLTEPATIL.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,233000000.0,KOLTEPATIL.NS
Special Income Charges,2024-03-31 00:00:00,-234600000.0,KOLTEPATIL.NS
Other Special Charges,2024-03-31 00:00:00,-3300000.0,KOLTEPATIL.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-978600000.0,KOLTEPATIL.NS
Total Other Finance Cost,2024-03-31 00:00:00,66200000.0,KOLTEPATIL.NS
Interest Expense Non Operating,2024-03-31 00:00:00,978600000.0,KOLTEPATIL.NS
Interest Income Non Operating,2024-03-31 00:00:00,76000000.0,KOLTEPATIL.NS
Operating Income,2024-03-31 00:00:00,369100000.0,KOLTEPATIL.NS
Operating Expense,2024-03-31 00:00:00,2585500000.0,KOLTEPATIL.NS
Other Operating Expenses,2024-03-31 00:00:00,1471900000.0,KOLTEPATIL.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,141900000.0,KOLTEPATIL.NS
Amortization,2024-03-31 00:00:00,7000000.0,KOLTEPATIL.NS
Depreciation Income Statement,2024-03-31 00:00:00,141900000.0,KOLTEPATIL.NS
Selling General And Administration,2024-03-31 00:00:00,724000000.0,KOLTEPATIL.NS
Selling And Marketing Expense,2024-03-31 00:00:00,487900000.0,KOLTEPATIL.NS
General And Administrative Expense,2024-03-31 00:00:00,236100000.0,KOLTEPATIL.NS
Rent And Landing Fees,2024-03-31 00:00:00,22200000.0,KOLTEPATIL.NS
Gross Profit,2024-03-31 00:00:00,2954600000.0,KOLTEPATIL.NS
Cost Of Revenue,2024-03-31 00:00:00,10760200000.0,KOLTEPATIL.NS
Total Revenue,2024-03-31 00:00:00,13714800000.0,KOLTEPATIL.NS
Operating Revenue,2024-03-31 00:00:00,13714800000.0,KOLTEPATIL.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,32408876.197275,KOLTEPATIL.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.325064,KOLTEPATIL.NS
Normalized EBITDA,2023-03-31 00:00:00,2082800000.0,KOLTEPATIL.NS
Total Unusual Items,2023-03-31 00:00:00,99700000.0,KOLTEPATIL.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,99700000.0,KOLTEPATIL.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,1040600000.0,KOLTEPATIL.NS
Reconciled Depreciation,2023-03-31 00:00:00,115600000.0,KOLTEPATIL.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,10892300000.0,KOLTEPATIL.NS
EBITDA,2023-03-31 00:00:00,2182500000.0,KOLTEPATIL.NS
EBIT,2023-03-31 00:00:00,2066900000.0,KOLTEPATIL.NS
Net Interest Income,2023-03-31 00:00:00,-342400000.0,KOLTEPATIL.NS
Interest Expense,2023-03-31 00:00:00,386000000.0,KOLTEPATIL.NS
Interest Income,2023-03-31 00:00:00,64300000.0,KOLTEPATIL.NS
Normalized Income,2023-03-31 00:00:00,973308876.197275,KOLTEPATIL.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,1040600000.0,KOLTEPATIL.NS
Total Expenses,2023-03-31 00:00:00,13066500000.0,KOLTEPATIL.NS
Rent Expense Supplemental,2023-03-31 00:00:00,18700000.0,KOLTEPATIL.NS
Diluted Average Shares,2023-03-31 00:00:00,76000000.0,KOLTEPATIL.NS
Basic Average Shares,2023-03-31 00:00:00,76000000.0,KOLTEPATIL.NS
Diluted EPS,2023-03-31 00:00:00,13.69,KOLTEPATIL.NS
Basic EPS,2023-03-31 00:00:00,13.69,KOLTEPATIL.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,1040600000.0,KOLTEPATIL.NS
Net Income Common Stockholders,2023-03-31 00:00:00,1040600000.0,KOLTEPATIL.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income,2023-03-31 00:00:00,1040600000.0,KOLTEPATIL.NS
Minority Interests,2023-03-31 00:00:00,-93900000.0,KOLTEPATIL.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,1134500000.0,KOLTEPATIL.NS
Net Income Extraordinary,2023-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Continuous Operations,2023-03-31 00:00:00,1134500000.0,KOLTEPATIL.NS
Tax Provision,2023-03-31 00:00:00,546400000.0,KOLTEPATIL.NS
Pretax Income,2023-03-31 00:00:00,1680900000.0,KOLTEPATIL.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,122000000.0,KOLTEPATIL.NS
Special Income Charges,2023-03-31 00:00:00,1500000.0,KOLTEPATIL.NS
Other Special Charges,2023-03-31 00:00:00,-1500000.0,KOLTEPATIL.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-342400000.0,KOLTEPATIL.NS
Total Other Finance Cost,2023-03-31 00:00:00,20700000.0,KOLTEPATIL.NS
Interest Expense Non Operating,2023-03-31 00:00:00,386000000.0,KOLTEPATIL.NS
Interest Income Non Operating,2023-03-31 00:00:00,64300000.0,KOLTEPATIL.NS
Operating Income,2023-03-31 00:00:00,1815200000.0,KOLTEPATIL.NS
Operating Expense,2023-03-31 00:00:00,2174200000.0,KOLTEPATIL.NS
Other Operating Expenses,2023-03-31 00:00:00,559000000.0,KOLTEPATIL.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,115600000.0,KOLTEPATIL.NS
Amortization,2023-03-31 00:00:00,7400000.0,KOLTEPATIL.NS
Depreciation Income Statement,2023-03-31 00:00:00,108200000.0,KOLTEPATIL.NS
Selling General And Administration,2023-03-31 00:00:00,626000000.0,KOLTEPATIL.NS
Selling And Marketing Expense,2023-03-31 00:00:00,444900000.0,KOLTEPATIL.NS
General And Administrative Expense,2023-03-31 00:00:00,181100000.0,KOLTEPATIL.NS
Rent And Landing Fees,2023-03-31 00:00:00,18700000.0,KOLTEPATIL.NS
Gross Profit,2023-03-31 00:00:00,3989400000.0,KOLTEPATIL.NS
Cost Of Revenue,2023-03-31 00:00:00,10892300000.0,KOLTEPATIL.NS
Total Revenue,2023-03-31 00:00:00,14881700000.0,KOLTEPATIL.NS
Operating Revenue,2023-03-31 00:00:00,14881700000.0,KOLTEPATIL.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-26118189.155477,KOLTEPATIL.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.37743,KOLTEPATIL.NS
Normalized EBITDA,2022-03-31 00:00:00,2036300000.0,KOLTEPATIL.NS
Total Unusual Items,2022-03-31 00:00:00,-69200000.0,KOLTEPATIL.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-69200000.0,KOLTEPATIL.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,794100000.0,KOLTEPATIL.NS
Reconciled Depreciation,2022-03-31 00:00:00,103900000.0,KOLTEPATIL.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,7722800000.0,KOLTEPATIL.NS
EBITDA,2022-03-31 00:00:00,1967100000.0,KOLTEPATIL.NS
EBIT,2022-03-31 00:00:00,1863200000.0,KOLTEPATIL.NS
Net Interest Income,2022-03-31 00:00:00,-500300000.0,KOLTEPATIL.NS
Interest Expense,2022-03-31 00:00:00,500300000.0,KOLTEPATIL.NS
Interest Income,2022-03-31 00:00:00,34000000.0,KOLTEPATIL.NS
Normalized Income,2022-03-31 00:00:00,837181810.844523,KOLTEPATIL.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,794100000.0,KOLTEPATIL.NS
Total Expenses,2022-03-31 00:00:00,9416700000.0,KOLTEPATIL.NS
Rent Expense Supplemental,2022-03-31 00:00:00,21400000.0,KOLTEPATIL.NS
Diluted Average Shares,2022-03-31 00:00:00,75990431.0,KOLTEPATIL.NS
Basic Average Shares,2022-03-31 00:00:00,75990431.0,KOLTEPATIL.NS
Diluted EPS,2022-03-31 00:00:00,10.45,KOLTEPATIL.NS
Basic EPS,2022-03-31 00:00:00,10.45,KOLTEPATIL.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,794100000.0,KOLTEPATIL.NS
Net Income Common Stockholders,2022-03-31 00:00:00,794100000.0,KOLTEPATIL.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income,2022-03-31 00:00:00,794100000.0,KOLTEPATIL.NS
Minority Interests,2022-03-31 00:00:00,-54400000.0,KOLTEPATIL.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,848500000.0,KOLTEPATIL.NS
Net Income Extraordinary,2022-03-31 00:00:00,-69200000.0,KOLTEPATIL.NS
Net Income Continuous Operations,2022-03-31 00:00:00,848500000.0,KOLTEPATIL.NS
Tax Provision,2022-03-31 00:00:00,514400000.0,KOLTEPATIL.NS
Pretax Income,2022-03-31 00:00:00,1362900000.0,KOLTEPATIL.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,190200000.0,KOLTEPATIL.NS
Special Income Charges,2022-03-31 00:00:00,-69200000.0,KOLTEPATIL.NS
Other Special Charges,2022-03-31 00:00:00,-500000.0,KOLTEPATIL.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-500300000.0,KOLTEPATIL.NS
Total Other Finance Cost,2022-03-31 00:00:00,78900000.0,KOLTEPATIL.NS
Interest Expense Non Operating,2022-03-31 00:00:00,500300000.0,KOLTEPATIL.NS
Interest Income Non Operating,2022-03-31 00:00:00,34000000.0,KOLTEPATIL.NS
Operating Income,2022-03-31 00:00:00,1758100000.0,KOLTEPATIL.NS
Operating Expense,2022-03-31 00:00:00,1693900000.0,KOLTEPATIL.NS
Other Operating Expenses,2022-03-31 00:00:00,884500000.0,KOLTEPATIL.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,103900000.0,KOLTEPATIL.NS
Amortization,2022-03-31 00:00:00,4800000.0,KOLTEPATIL.NS
Depreciation Income Statement,2022-03-31 00:00:00,103900000.0,KOLTEPATIL.NS
Selling General And Administration,2022-03-31 00:00:00,334100000.0,KOLTEPATIL.NS
Selling And Marketing Expense,2022-03-31 00:00:00,186600000.0,KOLTEPATIL.NS
General And Administrative Expense,2022-03-31 00:00:00,147500000.0,KOLTEPATIL.NS
Rent And Landing Fees,2022-03-31 00:00:00,21400000.0,KOLTEPATIL.NS
Gross Profit,2022-03-31 00:00:00,3452000000.0,KOLTEPATIL.NS
Cost Of Revenue,2022-03-31 00:00:00,7722800000.0,KOLTEPATIL.NS
Total Revenue,2022-03-31 00:00:00,11174800000.0,KOLTEPATIL.NS
Operating Revenue,2022-03-31 00:00:00,11174800000.0,KOLTEPATIL.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,KOLTEPATIL.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,KOLTEPATIL.NS
Normalized EBITDA,2021-03-31 00:00:00,,KOLTEPATIL.NS
Total Unusual Items,2021-03-31 00:00:00,,KOLTEPATIL.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,KOLTEPATIL.NS
Reconciled Depreciation,2021-03-31 00:00:00,,KOLTEPATIL.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,KOLTEPATIL.NS
EBITDA,2021-03-31 00:00:00,,KOLTEPATIL.NS
EBIT,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Interest Income,2021-03-31 00:00:00,,KOLTEPATIL.NS
Interest Expense,2021-03-31 00:00:00,,KOLTEPATIL.NS
Interest Income,2021-03-31 00:00:00,34000000.0,KOLTEPATIL.NS
Normalized Income,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,KOLTEPATIL.NS
Total Expenses,2021-03-31 00:00:00,,KOLTEPATIL.NS
Rent Expense Supplemental,2021-03-31 00:00:00,10800000.0,KOLTEPATIL.NS
Diluted Average Shares,2021-03-31 00:00:00,,KOLTEPATIL.NS
Basic Average Shares,2021-03-31 00:00:00,,KOLTEPATIL.NS
Diluted EPS,2021-03-31 00:00:00,,KOLTEPATIL.NS
Basic EPS,2021-03-31 00:00:00,,KOLTEPATIL.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,KOLTEPATIL.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income,2021-03-31 00:00:00,,KOLTEPATIL.NS
Minority Interests,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Income Extraordinary,2021-03-31 00:00:00,0.0,KOLTEPATIL.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,KOLTEPATIL.NS
Tax Provision,2021-03-31 00:00:00,,KOLTEPATIL.NS
Pretax Income,2021-03-31 00:00:00,,KOLTEPATIL.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,KOLTEPATIL.NS
Special Income Charges,2021-03-31 00:00:00,,KOLTEPATIL.NS
Other Special Charges,2021-03-31 00:00:00,,KOLTEPATIL.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,KOLTEPATIL.NS
Total Other Finance Cost,2021-03-31 00:00:00,56600000.0,KOLTEPATIL.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,KOLTEPATIL.NS
Interest Income Non Operating,2021-03-31 00:00:00,34000000.0,KOLTEPATIL.NS
Operating Income,2021-03-31 00:00:00,,KOLTEPATIL.NS
Operating Expense,2021-03-31 00:00:00,,KOLTEPATIL.NS
Other Operating Expenses,2021-03-31 00:00:00,,KOLTEPATIL.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,KOLTEPATIL.NS
Amortization,2021-03-31 00:00:00,4700000.0,KOLTEPATIL.NS
Depreciation Income Statement,2021-03-31 00:00:00,,KOLTEPATIL.NS
Selling General And Administration,2021-03-31 00:00:00,316300000.0,KOLTEPATIL.NS
Selling And Marketing Expense,2021-03-31 00:00:00,178300000.0,KOLTEPATIL.NS
General And Administrative Expense,2021-03-31 00:00:00,138000000.0,KOLTEPATIL.NS
Rent And Landing Fees,2021-03-31 00:00:00,10800000.0,KOLTEPATIL.NS
Gross Profit,2021-03-31 00:00:00,,KOLTEPATIL.NS
Cost Of Revenue,2021-03-31 00:00:00,,KOLTEPATIL.NS
Total Revenue,2021-03-31 00:00:00,,KOLTEPATIL.NS
Operating Revenue,2021-03-31 00:00:00,,KOLTEPATIL.NS
